Development and approval of rybelsus (oral semaglutide): ushering in a new era in peptide delivery
Crossref DOI link: https://doi.org/10.1007/s13346-021-01000-w
Published Online: 2021-05-22
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lewis, Andrew L.
McEntee, Nicholas
Holland, Justin
Patel, Asma
Text and Data Mining valid from 2021-05-22
Version of Record valid from 2021-05-22
Article History
Accepted: 30 April 2021
First Online: 22 May 2021